3-44594292-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173658.4(ZNF660):c.99G>T(p.Gln33His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173658.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249546Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135000
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461766Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727168
GnomAD4 genome AF: 0.000131 AC: 20AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 26, 2024 | The c.99G>T (p.Q33H) alteration is located in exon 3 (coding exon 1) of the ZNF660 gene. This alteration results from a G to T substitution at nucleotide position 99, causing the glutamine (Q) at amino acid position 33 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at